Pfizer supply chain challenges led to slashing COVID-19 vaccine production target - WSJ

(Reuters) - Challenges in Pfizer Inc's supply chain for its COVID-19 vaccine played a role in its decision to slash its 2020 production target, the Wall Street Journal reported on Thursday.

Reuters December 04, 2020 04:05:08 IST
Pfizer supply chain challenges led to slashing COVID-19 vaccine production target - WSJ

COVID-19 vaccine production target - WSJ" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/04/2020-12-03T214108Z_1_LYNXMPEGB21UY_RTROPTP_2_HEALTH-CORONAVIRUS-BRITAIN-VACCINE.jpg" alt="Pfizer supply chain challenges led to slashing COVID19 vaccine production target WSJ" width="300" height="225" />

(Reuters) - Challenges in Pfizer Inc's supply chain for its COVID-19 vaccine played a role in its decision to slash its 2020 production target, the Wall Street Journal reported on Thursday.

Pfizer has said in recent weeks that it anticipates producing 50 million doses of its COVID-19 vaccine this year. That is down from an earlier target of 100 million doses. Pfizer's vaccine relies on a two dose regimen, meaning 50 million doses is enough to inoculate 25 million people.

A company spokeswoman told the Journal "scaling up the raw material supply chain took longer than expected." She also cited later-than-expected results from Pfizer's clinical trial as a reason for the company's reduced expectations for vaccine production this year, the Journal reported.

The Journal reported that an unnamed person directly involved in the development of the Pfizer vaccine said “some early batches of the raw materials failed to meet the standards," which caused production delays.

Pfizer applied in November for emergency authorization for its COVID-19 vaccine from U.S. regulators. U.S. officials said they expect its vaccine to get regulatory clearance this month. The U.S. government expects its first allocation of the vaccine to include 6.4 million doses, with more to follow.

Regulators in the U.K. have already authorized Pfizer's vaccine for use in that country.

Pfizer did not immediately respond to a request for comment on the Journal's story.

(Reporting by Carl O'Donnell, editing by Peter Henderson and David Gregorio)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Suddenly overwhelmed, Ireland says thousands of COVID-19 cases yet to be added to tally
World

Suddenly overwhelmed, Ireland says thousands of COVID-19 cases yet to be added to tally

DUBLIN (Reuters) - Ireland said on Friday it had under-reported coronavirus cases in recent days by thousands more than previously known as its system came under strain, suggesting the EU's fastest growing outbreak is worsening even more rapidly than figures showed.

Rebuking Trump, Republican-led Senate overrides defense bill veto
World

Rebuking Trump, Republican-led Senate overrides defense bill veto

By David Morgan and Susan Heavey WASHINGTON (Reuters) - President Donald Trump's fellow Republicans in the U.S. Senate on Friday overrode his veto for the first time in his nearly four years in office, pushing through a defense policy bill against his strong objections weeks before he leaves office. Meeting in a rare New Year's Day session, the Senate voted 81-13 to secure the two-thirds majority needed to override the veto with bipartisan support

Republican-led Senate defies Trump, overrides defense bill veto
World

Republican-led Senate defies Trump, overrides defense bill veto

By David Morgan and Susan Heavey WASHINGTON (Reuters) - President Donald Trump's fellow Republicans in the U.S. Senate on Friday overrode his veto for the first time in his nearly four years in office, pushing through a bill on defense spending against his strong objections 20 days before he leaves office. Meeting in a rare New Year's Day session, the Senate secured the two-thirds majority needed to override the veto with bipartisan support two days before a new Congress will be sworn in on Sunday.